G C. Van Hasselt
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Reply to Srivastava and Gumbo, "Rigor and reproducibility of hollow-fiber infection model for antiviral pharmacokinetics/pharmacodynamics studies".
Journal: Antimicrobial agents and chemotherapy
Published: September 03, 2026
In reply to the Letter to Editor regarding: "Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa".
Journal: International journal of antimicrobial agents
Published: July 28, 2026
A novel hollow-fiber infection model (HFIM) for antiviral PK/PD studies of CMV infection.
Journal: Antimicrobial agents and chemotherapy
Published: June 18, 2026
Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms.
Journal: Biofilm
Published: May 30, 2026
Successful Translational Prediction of Bedaquiline's Phase 2a Clinical Trial Results against Tuberculosis: The Zebrafish as a New Approach Methodology.
Journal: Clinical pharmacology and therapeutics
Published: May 29, 2026
Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Journal: Clinical pharmacokinetics
Published: May 19, 2026
Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Journal: Clinical pharmacokinetics
Published: March 12, 2026
Defining the unbound target exposure of teicoplanin, Part 1: Insights from the hollow-fibre system.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 03, 2026
Defining the unbound target exposure of teicoplanin part 2: Dose individualization through population pharmacokinetic modelling.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 03, 2026
Experimental and virus-specific drivers of EC50 variability in antiviral assays evaluated using mathematical modeling.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: January 10, 2026
Assessing the impact of bacterial heterogeneity on bacteriophage population dynamics.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: November 07, 2025
Copulas for Covariate Simulation in Pharmacometrics.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 05, 2025
Last Updated: 09/26/2026